These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2746860)

  • 61. Synergistic antibacterial effect of Bi
    Ma L; Wu J; Wang S; Yang H; Liang D; Lu Z
    J Inorg Biochem; 2017 Mar; 168():38-45. PubMed ID: 28011210
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synergistic antibacterial interaction of cefotaxime and desacetylcefotaxime.
    Molinari G; Saverino D; Paglia P; Debbia EA; Schito GC
    J Chemother; 1991 Feb; 3(1):6-12. PubMed ID: 2019866
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interaction of cefotaxime and desacetylcefotaxime against pathogenic bacteria. Assessment with the serum bactericidal test.
    Reller LB
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):55S-61S. PubMed ID: 6086219
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synergistic interaction of cefotaxime and its metabolite desacetylcefotaxime demonstrated by drug-impregnated disks.
    Stevens DL; Bergstrom R; Gibbons A
    Diagn Microbiol Infect Dis; 1989; 12(1):73-80. PubMed ID: 2653715
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Additive Effect of MCP in Combination with Cefotaxime Against Staphylococcus aureus.
    Dahdouh E; El-Khatib S; Baydoun E; Abdel-Massih RM
    Med Chem; 2017; 13(7):682-688. PubMed ID: 28266280
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A novel STK1-targeted small-molecule as an "antibiotic resistance breaker" against multidrug-resistant Staphylococcus aureus.
    Kant S; Asthana S; Missiakas D; Pancholi V
    Sci Rep; 2017 Jul; 7(1):5067. PubMed ID: 28698584
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Methicillin potentiates the effect of gentamicin on methicillin-resistant Staphylococcus aureus.
    Hemmer RJ; Vaudaux P; Waldvogel FA
    Antimicrob Agents Chemother; 1979 Jan; 15(1):34-41. PubMed ID: 426504
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The combination effect of Korean red ginseng saponins with kanamycin and cefotaxime against methicillin-resistant Staphylococcus aureus.
    Sung WS; Lee DG
    Biol Pharm Bull; 2008 Aug; 31(8):1614-7. PubMed ID: 18670099
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Te-Cefotaxime nanocomposites with restored antibiotic susceptibility and the LED light activated photothermal effect for rapid MRSA eradication.
    Wu S; Liu X; Li Z; Lu Z; Jiang N; Yang H; Yao H
    J Mater Chem B; 2022 Mar; 10(10):1571-1581. PubMed ID: 35147632
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interactions of drugs acting against Staphylococcus aureus in vitro and in a mouse model.
    Renneberg J; Karlsson E; Nilsson B; Walder M
    J Infect; 1993 May; 26(3):265-77. PubMed ID: 8505561
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Fosfomycin-cefotaxime combination in severe staphylococcal infections in newborn infants].
    Gouyon JB; Duez JM; Portier H; Brichon P; Kohli E; Alison M
    Presse Med; 1985 Dec; 14(42):2135-8. PubMed ID: 2935798
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The effect of combinations of cefotiam and other antibiotics on methicillin-resistant Staphylococcus aureus in vitro.
    Sugiura A; Jono K; Kono T; Higashide E
    J Antimicrob Chemother; 1991 Nov; 28(5):707-17. PubMed ID: 1778874
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In vitro synergy and potentiation between cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides.
    Aldridge KE; Sanders CV; Marier RL
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):47S-53S. PubMed ID: 6086218
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In vivo antibacterial activity of cefodizime, a new cephalosporin antibiotic.
    Kasai K; Tsuji A; Miyazaki S; Goto S; Fujimoto K; Masuyoshi S; Arai S
    Jpn J Antibiot; 1984 Jul; 37(7):1306-12. PubMed ID: 6092740
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A reassessment of the activity of the third-generation cephalosporins against anaerobes and Staphylococcus aureus.
    Canawati HN
    Am J Surg; 1992 Oct; 164(4A Suppl):24S-27S. PubMed ID: 1443357
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synergic activity of imipenem/cilastatin combined with cefotiam against methicillin-resistant Staphylococcus aureus.
    Oka S; Goto M; Kaji Y; Kimura S; Matsuda K; Asahi Y; Sanada M; Nakagawa S; Inoue M; Shimada K
    J Antimicrob Chemother; 1993 Apr; 31(4):533-41. PubMed ID: 8514648
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synergistic effects of anacardic acids and methicillin against methicillin resistant Staphylococcus aureus.
    Muroi H; Nihei K; Tsujimoto K; Kubo I
    Bioorg Med Chem; 2004 Feb; 12(3):583-7. PubMed ID: 14738968
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Quantitative and qualitative determinations of the combined effect of tetracycline and oleandomycin. II. In vivo effect.
    Tone J; Shioji S; Kondo T; Kawakami M; Mitsuhashi S
    Jpn J Antibiot; 1976 May; 29(5):571-9. PubMed ID: 933343
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Combination effect of teicoplanin and beta-lactams on MRSA].
    Otsuka Y; Yoshibe T; Namioka M; Ezaki T
    Jpn J Antibiot; 2000 Dec; 53(12):643-51. PubMed ID: 11234220
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Experience with cefotaxime in infections caused by gram-positive pathogens, especially Staphylococcus aureus.
    Fujii R
    Infection; 1985; 13 Suppl 1():S9-13. PubMed ID: 4055062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.